Skip NavigationSkip to Content

HLA-A*3101 and Carbamazepine-Induced Hypersensitivity Reactions in Europeans

  1. Author:
    McCormack, M.
    Alfirevic, A.
    Bourgeois, S.
    Farrell, J. J.
    Kasperaviciute, D.
    Carrington, M.
    Sills, G. J.
    Marson, T.
    Jia, X. M.
    de Bakker, P. I. W.
    Chinthapalli, K.
    Molokhia, M.
    Johnson, M. R.
    O'Connor, G. D.
    Chaila, E.
    Alhusaini, S.
    Shianna, K. V.
    Radtke, R. A.
    Heinzen, E. L.
    Walley, N.
    Pandolfo, M.
    Pichler, W.
    Park, B. K.
    Depondt, C.
    Sisodiya, S. M.
    Goldstein, D. B.
    Deloukas, P.
    Delanty, N.
    Cavalleri, G. L.
    Pirmohamed, M.
  2. Author Address

    [Alfirevic, Ana] Univ Liverpool, Wolfson Ctr Personalised Med, Dept Mol & Clin Pharmacol, Inst Translat Med, Liverpool L69 3GL, Merseyside, England. [McCormack, Mark; Alhusaini, Saud; Delanty, Norman; Cavalleri, Gianpiero L.] Royal Coll Surgeons Ireland, Dublin 2, Ireland. [O'Connor, Gerard D.; Chaila, Elijah; Delanty, Norman] Beaumont Hosp, Div Neurol, Dublin 9, Ireland. [Marson, Tony] Walton Ctr Neurol, Liverpool, Merseyside, England. [Bourgeois, Stephane; Deloukas, Panos] Wellcome Trust Sanger Inst, Hinxton, England. [Chinthapalli, Krishna; Sisodiya, Sanjay M.] Natl Soc Epilepsy, Gerrards Cross, Bucks, England. [Farrell, John J.] Boston Univ, Dept Med, Boston, MA 02215 USA. [Carrington, Mary] Harvard Univ, Massachusetts Gen Hosp, MIT, Sch Med,Ragon Inst, Boston, MA USA. [Jia, Xiaoming] Harvard Univ, Sch Med, Harvard MIT Div Hlth Sci & Technol, Boston, MA 02115 USA. [de Bakker, Paul I. W.] Harvard Univ, Brigham & Womens Hosp, Div Genet, Dept Med,Med Sch, Boston, MA 02115 USA. [Kasperaviciute, Dalia; Chinthapalli, Krishna; Sisodiya, Sanjay M.] UCL, Dept Clin & Expt Epilepsy, Inst Neurol, London, England. [Molokhia, Mariam] Kings Coll London, Dept Primary Care & Publ Hlth Sci, Div Hlth & Social Care Res, London WC2R 2LS, England. [Johnson, Michael R.] Univ London Imperial Coll Sci Technol & Med, Dept Med, Ctr Neurosci, London, England. [Carrington, Mary] NCI, Canc & Inflammat Program, Lab Expt Immunol, SAIC Frederick, Frederick, MD 21701 USA. [de Bakker, Paul I. W.] Harvard & MIT, Broad Inst, Program Med & Populat Genet, Cambridge, MA USA. [de Bakker, Paul I. W.] Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands. [de Bakker, Paul I. W.] Univ Med Ctr, Dept Med Genet, Div Biomed Genet, Utrecht, Netherlands. [Shianna, Kevin V.; Heinzen, Erin L.; Walley, Nicole; Goldstein, David B.] Duke Univ, Sch Med, Ctr Human Genome Variat, Durham, NC USA. [Radtke, Rodney A.] Duke Univ, Sch Med, Dept Med Neurol, Durham, NC USA. [Pandolfo, Massimo; Depondt, Chantal] Univ Libre Bruxelles, Dept Neurol, Hop Erasme, Brussels, Belgium. [Pichler, Werner] Univ Bern, Dept Rheumatol Clin Immunol & Allergol, Bern, Switzerland.;Alfirevic, A, Univ Liverpool, Wolfson Ctr Personalised Med, Dept Mol & Clin Pharmacol, Inst Translat Med, Block A,Waterhouse Bldgs,1-5 Brownlow St, Liverpool L69 3GL, Merseyside, England.;ana.alfirevic@liv.ac.uk
    1. Year: 2011
    2. Date: Mar
  1. Journal: New England Journal of Medicine
    1. 364
    2. 12
    3. Pages: 1134-1143
  2. Type of Article: Article
  3. ISSN: 0028-4793
  1. Abstract:

    BACKGROUND Carbamazepine causes various forms of hypersensitivity reactions, ranging from maculopapular exanthema to severe blistering reactions. The HLA-B*1502 allele has been shown to be strongly correlated with carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS-TEN) in the Han Chinese and other Asian populations but not in European populations. METHODS We performed a genomewide association study of samples obtained from 22 subjects with carbamazepine-induced hypersensitivity syndrome, 43 subjects with carbamazepine-induced maculopapular exanthema, and 3987 control subjects, all of European descent. We tested for an association between disease and HLA alleles through proxy single-nucleotide polymorphisms and imputation, confirming associations by high-resolution sequence-based HLA typing. We replicated the associations in samples from 145 subjects with carbamazepine-induced hypersensitivity reactions. RESULTS The HLA-A*3101 allele, which has a prevalence of 2 to 5% in Northern European populations, was significantly associated with the hypersensitivity syndrome (P = 3.5x10(-8)). An independent genomewide association study of samples from subjects with maculopapular exanthema also showed an association with the HLAA*3101 allele (P = 1.1x10(-6)). Follow-up genotyping confirmed the variant as a risk factor for the hypersensitivity syndrome (odds ratio, 12.41; 95% confidence interval [CI], 1.27 to 121.03), maculopapular exanthema (odds ratio, 8.33; 95% CI, 3.59 to 19.36), and SJS-TEN (odds ratio, 25.93; 95% CI, 4.93 to 116.18). CONCLUSIONS The presence of the HLA-A* 3101 allele was associated with carbamazepine-induced hypersensitivity reactions among subjects of Northern European ancestry. The presence of the allele increased the risk from 5.0% to 26.0%, whereas its absence reduced the risk from 5.0% to 3.8%.

    See More

External Sources

  1. WOS: 000288701100008

Library Notes

  1. Fiscal Year: FY2010-2011
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel